Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: BLEXBot Disallow: / User-agent: Twitterbot Disallow: User-agent: * Disallow: /action/ Disallow: /publish Disallow: /sign-in Disallow: /channel-frame Disallow: /feed/private Disallow: /feed/podcast/*/private/*.rss Disallow: /subscribe Disallow: /lovestack/* Disallow: /p/*/comment/* Disallow: /inbox/post/* Disallow: /notes/post/* Disallow: |
Title | BioPharma Observer | Stewart Lyman | |
Description | All things considered in biopharma and biomedicine. Click to read BioPharma Observer, by Stewart Lyman, a Substack publication. Launched 10 months |
Keywords | N/A |
WebSite | lymanbiopharma.com |
Host IP | 199.204.248.117 |
Location | United States |
Site | Rank |
US$289,950
Last updated: 2023-05-07 19:20:30
lymanbiopharma.com has Semrush global rank of 36,503,958. lymanbiopharma.com has an estimated worth of US$ 289,950, based on its estimated Ads revenue. lymanbiopharma.com receives approximately 33,456 unique visitors each day. Its web server is located in United States, with IP address 199.204.248.117. According to SiteAdvisor, lymanbiopharma.com is safe to visit. |
Purchase/Sale Value | US$289,950 |
Daily Ads Revenue | US$268 |
Monthly Ads Revenue | US$8,030 |
Yearly Ads Revenue | US$96,353 |
Daily Unique Visitors | 2,231 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
lymanbiopharma.com. | A | 7199 | IP: 199.204.248.117 |
lymanbiopharma.com. | NS | 86400 | NS Record: ns3.machighway.com. |
lymanbiopharma.com. | NS | 86400 | NS Record: ns4.machighway.com. |
lymanbiopharma.com. | NS | 86400 | NS Record: ns2.machighway.com. |
lymanbiopharma.com. | NS | 86400 | NS Record: ns1.machighway.com. |
lymanbiopharma.com. | MX | 14400 | MX Record: 0 lymanbiopharma.com. |
lymanbiopharma.com. | TXT | 300 | TXT Record: v=spf1 +a +mx +ip4:199.204.248.117 +include:relay.mailchannels.net -all |
BioPharma Observer Subscribe Sign in Home Archive About Master Publication’s List All of my articles, no matter where they were published Jul 12, 2022 • Stewart Lyman Share this post Master Publication’s List stewartlyman.substack.com Copy link Twitter Facebook Email Notes New Top The History of Drug Discovery and Development in Seattle Drug discovery and development is a difficult process that takes considerable expertise in both the research and business realms. Seattle (and the rest… Mar 22 • Stewart Lyman 1 Share this post The History of Drug Discovery and Development in Seattle stewartlyman.substack.com Copy link Twitter Facebook Email Notes Welcome to the Seattle Biotech Graveyard This page details the fates of a number of Seattle or NW based biotech companies that are no longer with us because they were acquired, merged, or… Mar 21 • Stewart Lyman Share this post Welcome to the Seattle Biotech Graveyard stewartlyman.substack.com Copy link Twitter Facebook Email Notes Book |
HTTP/1.1 302 Found Date: Thu, 28 Oct 2021 14:56:39 GMT Server: Apache/2.4.51 (cPanel) OpenSSL/1.1.1l mod_bwlimited/1.4 Location: https://www.lymanbiopharma.com/ Content-Type: text/html; charset=iso-8859-1 HTTP/1.1 200 OK Date: Thu, 28 Oct 2021 14:56:39 GMT Server: Apache/2.4.51 (cPanel) OpenSSL/1.1.1l mod_bwlimited/1.4 Last-Modified: Sat, 11 Sep 2021 17:58:08 GMT ETag: "3341acf-28bf-5cbbbf9810a66" Accept-Ranges: bytes Content-Length: 10431 Content-Type: text/html |
Domain Name: LYMANBIOPHARMA.COM Registry Domain ID: 618833179_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.enom.com Registrar URL: http://www.enomdomains.com Updated Date: 2021-09-12T23:36:08Z Creation Date: 2006-10-04T17:25:03Z Registry Expiry Date: 2022-10-04T17:25:03Z Registrar: eNom, LLC Registrar IANA ID: 48 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS1.MACHIGHWAY.COM Name Server: NS2.MACHIGHWAY.COM DNSSEC: unsigned >>> Last update of whois database: 2021-09-16T07:06:17Z <<< |